Top Markets
#1 Black Phoenix Black Phoenix +355.18%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +53.98%
#5 Acurast Acurast +28.90%
#6 BasedHype BasedHype +28.07%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +18.15%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.84%
#10 HOME HOME +15.01%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
주식 순위 #40876
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
주가
$0.0127
마지막 동기화: 2026-08-12
시가총액
$66.48K
변동 (1일)
-2.31%
변동 (1년)
-67.44%
국가
US
거래 Vincerx Pharma, Inc. (VINC)

카테고리

Healthcare
Vincerx Pharma, Inc. (VINC)의 주식 분할 이력
Vincerx Pharma, Inc. 주식 (심볼: VINC)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 13, 2026에 발생했습니다.
Aug 13, 2026 이전에 매수한 VINC 주식 1주는 현재 0주의 VINC 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE